Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE

Wisconsin To Get $4 million in Multistate Drug Lawsuit

By Pharmaceutical Processing | May 12, 2010

MADISON, Wis. (AP) — Attorney General J.B. Van Hollen said Tuesday that Wisconsin will get more than $4 million in a multistate settlement with drug manufacturer AstraZeneca.

The drug maker allegedly marketed the anti-psychotic drug Seroquel for uses not approved by federal regulators, including treating insomnia and other psychiatric conditions.

The federal government and the states reached a $520 million settlement with AstraZeneca in April. The company will pay $9.9 million attributable to Wisconsin Medicaid. About $4.4 million of will go to the state. The rest will go to the federal government.

AstraZeneca spokesman Tony Jewell pointed to a statement company attorney Glenn Engelmann issued in April. Engelmann said the company denies the allegations but it was important to resolve them.

Van Hollen also announced the state will receive more than $264,000 as part of a $72.5 million multistate settlement with Novartis Pharmaceuticals Corp and Novartis Vaccines & Diagnostics, Inc. In addition, $395,000 will be attributable to Wisconsin Medicaid.

Van Hollen said the agreement resolves allegations the company promoted tobramycin, a cystic fibrosis drug, for uses not approved by federal regulators.

A spokeswoman for Novartis did not immediately return a phone message Tuesday.

 

Related Articles Read More >

Doctor, woman patient and tablet for consulting with results, medical info and talk for healthcare with mockup space. Japanese medic, digital touchscreen or show video for surgery, wellness or advice.
Putting patients first in clinical trials
Confidently navigate the transition from bench to batch
Merck
FDA approves Merck’s Winrevair to treat pulmonary arterial hypertension
kobayashi pharmaceutical logo
Report: Japan health authorities investigate Kobayashi Pharmaceutical factory after five deaths
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE